Factors such as reduced cost of sequencing with the use of NGS informatics, increase in initiatives from government to promote use of NGS in R&D, enhanced speed & flexibility offered by NGS, and continuous innovation & developments in the technology drive the growth of the global next-generation sequencing informatics market.

Portland, OR -- (SBWire) -- 08/22/2017 --The Next-Generation DNA Sequencing (NGS) technology has made genome and RNA sequencing cost-effective, and can be frequently used as a tool for a wide variety of research applications. This technology uses the bioinformatics methods to support DNA sequencing for researchers and organizations, making DNA sequencing easier.

Early Buyers Will Receive 20% Customization on This Report.

Factors such as reduced cost of sequencing with the use of NGS informatics, increase in initiatives from government to promote use of NGS in R&D, enhanced speed & flexibility offered by NGS, and continuous innovation & developments in the technology drive the growth of the global next-generation sequencing informatics market. However, lack of accuracy, precision, and standardization of the technology and dependence on government initiatives for the development of NGS technology hinder the market growth. Increased incorporation of NGS technology with other research programs and untapped market opportunities in emerging nations are expected to provide growth opportunities for the market.

The global next-generation sequencing informatics market is segmented on the basis of product, technology, application, and region. Based on product, the market is categorized into data analysis & management tool, NGS informatics services, and data interpretation & reporting tools. The data analysis & management tools segment is subsegmented into LIMS and computing tools. By technology, the market is classified into whole targeted re-sequencing, genome sequencing, de novo sequencing, exome sequencing, RNA sequencing, chip sequencing, and methyl sequencing. Applications covered in the study include diagnostics, drug discovery, biomarker discovery, personalized medicine, and agriculture & animals research. Geographically, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Request for Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/2824

The key players operating in the global NGS bioinformatics market are Burhani Guards International, GENEWIZ, GATC Biotech AG, Biomatters Ltd., DNASTAR, Genomatix GmbH, Qiagen N.V., Illumina Inc., Thermo Fisher Scientific Inc., and Partek Incorporated.